Application of oroxin B and drug containing oroxin B
A technology of oreoside and medicine, applied in the field of medicinal chemistry
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] Example 1 Inhibitory effect of orinetoside B on the growth of various tumor cells
[0046] Experimental Materials:
[0047] (1) Tumor cell lines
[0048] The 30 strains of human tumor cells used in the anti-tumor cell test of oreoside B are as follows: human Burkitt's lymphoma cells (Raji, Namalva), human T-lymphocytic leukemia cells (Jurkat), human melanoma highly metastatic cell lines (C8161), Human monocytic leukemia cells (THP-1), human myeloid leukemia cells (HL-60), human T lymphocytes (H9), human histiocytic lymphoma cells (U937), human glioma cells (SHG44) , human chronic myelogenous leukemia cells (K562), human brain astroglioblastoma (U-87MG), human gastric cancer cells (HGC-27), human cecal adenocarcinoma cells (Hce-8693), human glioma Cell tumor cells (A172), human malignant embryonic rhabdomyoma cells (RD), human osteosarcoma cells (U-2OS, LP-1), human liver cancer cells (HepG2, HCCC-9810), human cervical cancer intestinal metastasis cells (Caski) , huma...
Embodiment 2
[0059] Example 2 Selective Inhibitory Effect of Oriperoside B on the Growth of Malignant Lymphoma Cells in Vitro
[0060] Experimental Materials:
[0061] (1) Tumor cell lines: B lymphoma Raji and Namalwa cell lines, and non-tumorigenic lymphoblastoid HMY2-CIR were derived from ATCC in the United States. The cell culture medium DMEM (high sugar) is a product of Hyclone Company.
[0062] (2) Tested drug: Oreoside B was solubilized with dimethyl sulfoxide (DMSO), and diluted with DMEM (high glucose) medium to the desired concentration (0-40 μmol / L).
[0063] experimental method:
[0064] Lympholyte-H is used to separate the blood of normal people. The main steps of the experiment are: After drawing the peripheral blood of normal people (adding heparin), the peripheral blood is slowly added to the centrifuge tube with Lympholyte-H separation solution In the process, centrifuge to remove the middle mononuclear cell layer, wash twice with PBS, remove the separation fluid and pla...
Embodiment 3
[0069] Example 3 Oriperoside B effectively reduces the tumorigenicity of malignant lymphoma cells
[0070] Experimental Materials:
[0071] (1) Tumor cell line: B lymphoma Raji was derived from ATCC in the United States. The cell culture medium DMEM (high sugar) is a product of Hyclone Company.
[0072] (2) Tested drug: Oreoside B was solubilized with dimethyl sulfoxide (DMSO), and diluted with DMEM (high glucose) medium to the desired concentration (0-20 μmol / L).
[0073] experimental method:
[0074] Colony formation ability is the gold standard for measuring cell tumorigenicity, so this embodiment uses colony formation experiments to determine whether the tumorigenicity of malignant lymphoma Raji cells after being treated with oreoside B is reduced. The specific method is: Raji cells are treated with different After 48 hours of treatment with oleoside B (0, 5, 10, 20 μmol / L), the cells were collected and counted, and 600 viable cells were taken for each concentration and...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com